Goldman Sachs’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-130,342
Closed -$90K 5631
2020
Q2
$90K Buy
130,342
+85,651
+192% +$68.9K ﹤0.01% 5006
2020
Q1
$38K Buy
44,691
+18,918
+73% +$27K ﹤0.01% 5077
2019
Q4
$42K Sell
25,773
-36,728
-59% -$55.1K ﹤0.01% 5130
2019
Q3
$69K Buy
62,501
+40,558
+185% +$46.9K ﹤0.01% 5012
2019
Q2
$27K Buy
21,943
+4,492
+26% +$5.72K ﹤0.01% 5050
2019
Q1
$25K Buy
17,451
+6,207
+55% +$9.2K ﹤0.01% 5040
2018
Q4
$13K Sell
11,244
-1,257
-10% -$1.86K ﹤0.01% 5169
2018
Q3
$17K Sell
12,501
-7,616
-38% -$12.1K ﹤0.01% 5429
2018
Q2
$46K Buy
+20,117
New +$38.9K ﹤0.01% 5372
2017
Q4
Sell
-28,752
Closed -$33K 6796
2017
Q3
$33K Sell
28,752
-61,860
-68% -$78K ﹤0.01% 6345
2017
Q2
$158K Buy
90,612
+5,250
+6% +$11.2K ﹤0.01% 5924
2017
Q1
$225K Buy
85,362
+57,065
+202% +$205K ﹤0.01% 5655
2016
Q4
$120K Sell
28,297
-42,364
-60% -$140K ﹤0.01% 6056
2016
Q3
$189K Sell
70,661
-127,533
-64% -$293K ﹤0.01% 5866
2016
Q2
$351K Sell
198,194
-48,631
-20% -$99.2K ﹤0.01% 5207
2016
Q1
$573K Sell
246,825
-87,549
-26% -$198K ﹤0.01% 4611
2015
Q4
$1.16M Buy
334,374
+112,575
+51% +$539K ﹤0.01% 4151
2015
Q3
$1.36M Buy
221,799
+69,937
+46% +$474K ﹤0.01% 4172
2015
Q2
$1M Sell
151,862
-59,047
-28% -$398K ﹤0.01% 4540
2015
Q1
$1.5M Buy
+210,909
New +$1.59M ﹤0.01% 4060

Other funds holding GEN

Goldman Sachs's GEN Position: Q3 2020 in Review

Goldman Sachs sold out of Genesis Healthcare, Inc. (GEN) in Q3 2020, closing a stake of 130,342 shares — an estimated $90K sold.

Goldman Sachs first reported a position in GEN in Q1 2015 and held it in 20 quarters. The position peaked at $1.5M in Q1 2015. 55 funds tracked by Wall St. Rank hold GEN as of Q3 2020.

  • Goldman Sachs reported no remaining Genesis Healthcare, Inc. position as of Q3 2020 after selling out during the quarter.
  • Goldman Sachs sold 130,342 Genesis Healthcare, Inc. shares in Q3 2020, an estimated $90K.
  • Goldman Sachs first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 20 quarters.
  • Goldman Sachs's Genesis Healthcare, Inc. position peaked at $1.5M in Q1 2015.
  • 55 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q3 2020.

Based on Goldman Sachs's 13F filing for Q3 2020, filed 13 Nov 2020.